Initial experience with the intravascular contrast agent NC100150‐injection (Clariscan®) for breath‐hold and navigator‐gated magnetic resonance coronary artery imaging

Publisher Website
Google Scholar
Abstract
Purpose To examine magnetic resonance coronary artery imaging after NC100150‐Injection. Materials and Methods Breath‐hold and navigator‐gated images were acquired in five patients. Results Breath‐hold image quality, coronary artery‐fat SDNR, and coronary artery SNR improved. Respiratory artifacts due to reduced liver signal intensity degraded navigator‐gated image quality. Conclusion NC100150‐Injection improves breath‐hold coronary artery imaging. Navigator‐gated acquisitions should use techniques that are insensitive to T2* effects. J. Magn. Reson. Imaging 2002;16:217–223.
Funding Information
  • CORDA the Heart Charity
  • Wellcome Trust